Stock Price
298.86
Daily Change
-1.02 -0.34%
Monthly
-4.05%
Yearly
4.35%
Q3 Forecast
296.92

Cochlear reported AUD383.1M in Cash and Equivalent for its fiscal semester ending in December of 2024.




Cash And Equivalent Change Date
Ansell USD 912.3M 747.2M Jun/2024
Avita Medical AUD 14.05M 3.4M Dec/2024
Cochlear AUD 383.1M 130.5M Dec/2024
CSL USD 1.52B 133M Dec/2024
Fisher Paykel Healthcare NZD 264.5M 147.9M Mar/2025
Healius AUD 60.1M 25.6M Jun/2024
Integral Diagnostics AUD 17.99M 15.86M Dec/2023
Mayne Pharma AUD 110.07M 838K Jun/2024
Mesoblast USD 62.56M 14.58M Jun/2024
Monash IVF AUD 7.5M 3.83M Dec/2024
Nanosonics AUD 4.84M 124.71M Dec/2024
Polynovo AUD 45.91M 330K Jun/2024
Ramsay Health Care AUD 341.1M 321.2M Dec/2024
Regis Healthcare AUD 64.9M 21.69M Jun/2024
ResMed USD 1.21B 687.51M Jun/2025
Sigma Healthcare AUD 16.65M 3.68M Jan/2023
Sonic Healthcare AUD 645M 25.39M Jun/2024
Telix Pharmaceuticals AUD 710.35M 587.11M Dec/2024